Related Experiment Video
Updated: Dec 6, 2025

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
The effect of concomitant COVID-19 infection on outcomes in patients hospitalized with heart failure
Nikhil Chatrath1, Nandita Kaza1, Punam A Pabari1
1Department of Cardiology, Imperial College Healthcare NHS Trust, London, UK.
Insights
Patients with heart failure (HF) hospitalized with COVID-19 infection face a significantly higher risk of in-hospital death. This highlights the critical need to protect HF patients from COVID-19 exposure.
Area of Science:
- Cardiology
- Infectious Diseases
- Critical Care Medicine
Background:
- Patients with cardiovascular disease, particularly heart failure (HF), are recognized as a vulnerable population during the COVID-19 pandemic.
- The specific impact of COVID-19 infection on mortality and complications in hospitalized HF patients remained largely unknown prior to this study.
Purpose of the Study:
- To quantify the effect of COVID-19 infection on in-hospital mortality among patients with a pre-existing diagnosis of heart failure.
- To assess the association between COVID-19 infection and adverse outcomes such as acute kidney injury and myocardial injury in HF patients.
Main Methods:
- A retrospective analysis was conducted on 134 patients hospitalized with a diagnosis of heart failure between March 1 and May 6, 2020.
- The study compared outcomes, including in-hospital mortality, acute kidney injury, and myocardial injury, between HF patients with and without concomitant COVID-19 infection.
Main Results:
- Of 134 hospitalized HF patients, 40 (29.9%) had COVID-19. These patients experienced significantly higher in-hospital mortality (50.0% vs. 10.6%).
- COVID-19 positive HF patients were more likely to develop acute kidney injury (45% vs. 24.5%), myocardial injury (57.5% vs. 31.9%), and require treatment for superadded bacterial infections (55% vs. 32.5%).
Conclusions:
- Hospitalized patients with heart failure who contract COVID-19 have a very poor prognosis.
- This study underscores the necessity of identifying heart failure patients as a high-risk group requiring specific shielding strategies to mitigate COVID-19 risks.
Aims:
Patients with cardiovascular disease appear particularly susceptible to severe COVID-19 disease, but the impact of COVID-19 infection on patients with heart failure (HF) is not known. This study aimed to quantify the impact of COVID-19 infection on mortality in hospitalized patients known to have HF.
Methods And Results:
We undertook a retrospective analysis of all patients admitted with a pre-existing diagnosis of HF between 1 March and 6 May 2020 to our unit. We assessed the impact of concomitant COVID-19 infection on in-hospital mortality, incidence of acute kidney injury, and myocardial injury. One hundred and thirty-four HF patients were hospitalized, 40 (29.9%) with concomitant COVID-19 infection. Those with COVID-19 infection had a significantly increased in-hospital mortality {50.0% vs. 10.6%; relative risk [RR] 4.70 [95% confidence interval (CI) 2.42-9.12], P < 0.001} and were more likely to develop acute kidney injury [45% vs. 24.5%; RR 1.84 (95% CI 1.12-3.01), P = 0.02], have evidence of myocardial injury [57.5% vs. 31.9%; RR 1.81 (95% CI 1.21-2.68), P < 0.01], and be treated for a superadded bacterial infection [55% vs. 32.5%; RR 1.67 (95% CI 1.12-2.49), P = 0.01].
Conclusions:
Patients with HF admitted to hospital with concomitant COVID-19 infection have a very poor prognosis. This study highlights the need to regard patients with HF as a high-risk group to be shielded to reduce the risks of COVID-19 infection.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Related Concept Videos
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Pathophysiology of Heart Failure